Drug Information

Drug General Information
Drug ID
D0A3CL
Former ID
DIB001791
Drug Name
AZD1979
Indication Obesity [ICD9: 278; ICD10:E66] Phase 1 [524658]
Target and Pathway
Target(s) Melanin-concentrating hormone receptor 1 Target Info Modulator [550345]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Peptide ligand-binding receptors
G alpha (q) signalling events
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
References
Ref 524658ClinicalTrials.gov (NCT02072993) A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males. U.S. National Institutes of Health.
Ref 550345Phase I clinical trial of AZD1979 for treating obesity. AstraZeneca plc

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.